GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a truly shift in how we approach type 2 diabetes . These new medications help stimulating the body’s inherent GLP-1 hormone , which promotes https://bookmarksaifi.com/story21787359/glp-1-a-significant-advance-in-diabetes-treatment